Dalfampridine Tablet, Film Coated, Extended Release
Product Images NDC 63629-9450

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dalfampridine (NDC 63629-9450). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dalfampridine-equa (Dalfampridine Equa)

A formula depicting creatinine clearance (Crcl) calculated using age, weight in kilograms, serum creatinine in mg/dL, and a constant factor 72. The formula is not specific to the Dalfampridine product but relates to pharmacokinetic calculations involving kidney function.*

FDA Label Image

Dalfampridine-figure1 (Dalfampridine Figure1)

A bar chart comparing percentages of patients achieving various thresholds of average percent increase in walking speed from baseline between placebo and Dalfampridine Extended-release Tablets 10 mg b.i.d. The x-axis shows thresholds from 0% to ≥60%, and the y-axis shows patient percentages. Bars show higher percentages for Dalfampridine at most thresholds with associated p-values indicating statistical comparison.*

FDA Label Image

Dalfampridine-figure2 (Dalfampridine Figure2)

A bar chart comparing the percentage of patients showing average percent increases in walking speed from baseline for Dalfampridine extended-release tablets 10 mg b.i.d. versus placebo. The x-axis shows thresholds of walking speed increase (0% to ≥60%) and the y-axis shows the percentage of patients. P values are provided for each threshold comparison between the two groups.*

FDA Label Image

Dalfampridine-struc (Dalfampridine Struc)

Chemical structure diagram of Dalfampridine, showing a six-membered heterocyclic ring with a nitrogen atom and an amino group (NH2) attached to the ring.*

FDA Label Image

Label (Lbl636299450)

The label displays Dalfampridine Extended-release Tablets, each containing 10 mg of Dalfampridine. It is an oral, film-coated, extended-release tablet. The label indicates a package of 60 tablets by Bryant Ranch Prepack with NDC 63629-9450-01. It includes storage instructions and pharmacist dispensing guidance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.